GLOBAL ROBOTIC PROSTATE LTD

Executive Summary

Global Robotic Prostate Ltd is a newly incorporated micro-entity operating in specialist medical practice with no employees and limited assets but currently maintains a positive working capital position and regulatory compliance. While financial solvency appears sound, the absence of operational history and limited scale warrant further investigation into business plans and cash flow sustainability. Overall, the company presents a low immediate financial risk but remains unproven operationally.

GLOBAL ROBOTIC PROSTATE LTD - Analysis Report

Company Number: 15210522

Analysis Date: 2025-07-29 14:04 UTC

1. Risk Rating: LOW
   The company appears financially solvent with positive net current assets and no overdue filings. The micro-entity status and recent incorporation imply limited operational history but no immediate financial distress is evident.

2. Key Concerns:

• Very limited operational history since incorporation in October 2023, which increases uncertainty about business sustainability and revenue generation.
• No employees reported during the financial year, which may indicate reliance on directors or outsourced services and potential operational scale limitations.
• Small asset base and minimal fixed assets suggest limited capital investment to date, which may constrain growth or operational capability.

3. Positive Indicators:

• Healthy net current assets (£21,783) and shareholders’ funds (£24,182) indicate the company currently has sufficient short-term resources to cover liabilities.
• No overdue accounts or confirmation statement filings, demonstrating compliance with regulatory requirements.
• Clear governance with two directors and identifiable people with significant control, supporting transparency and accountability.

4. Due Diligence Notes:

• Investigate planned business activities and revenue projections to assess operational sustainability given the absence of employees and minimal assets.
• Confirm cash flow sources and working capital management, including any loans or shareholder funding arrangements supporting liquidity.
• Review any contracts, intellectual property, or operational agreements underpinning the specialist medical practice to understand business model viability.
• Verify directors’ backgrounds and their experience in the medical sector to gauge management capability.